Type 2 innate lymphoid cells impair IL-33-mediated tumor suppression

被引：0
|
作者：
Long, Alan W. [1 ]
Dominguez, Donye [1 ]
Qin, Lei [1 ]
Zhang, Minghui [2 ]
Fan, Jie [1 ]
Zhang, Bin [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
[2] Zhengzhou Univ, Zhengzhou, Henan, Peoples R China
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
124.13
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Quantitative phosphoproteomic analysis of IL-33-mediated signaling
    Pinto, Sneha M.
    Nirujogi, Raja Sekhar
    Leal Rojas, Pamela
    Patil, Arun H.
    Manda, Srikanth S.
    Subbannayya, Yashwanth
    Carlos Roa, Juan
    Chatterjee, Aditi
    Prasad, T. S. Keshava
    Pandey, Akhilesh
    PROTEOMICS, 2015, 15 (2-3) : 532 - 544
  • [22] Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33
    Christianson, Christina A.
    Goplen, Nicholas P.
    Zafar, Iram
    Irvin, Chaoyu
    Good, James T., Jr.
    Rollins, Donald R.
    Gorentla, Balachandra
    Liu, Weimin
    Gorska, Magdalena M.
    Chu, HongWei
    Martin, Richard J.
    Alam, Rafeul
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (01) : 59 - U142
  • [23] Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy
    McSorley, H. J.
    Blair, N. F.
    Smith, K. A.
    McKenzie, A. N. J.
    Maizels, R. M.
    MUCOSAL IMMUNOLOGY, 2014, 7 (05) : 1068 - 1078
  • [24] IL-33-mediated mast cell function is female dominant
    Maldonado, Tania
    Ryan, John
    Kee, Sydney
    Ching, John
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [25] Dexamethasone suppresses IL-33-mediated mast cell activation
    Chernushevich, Oksana
    Paranjape, Anuya
    Ryan, John
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [26] IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells
    Camelo, Ana
    Rosignoli, Guglielmo
    Ohne, Yoichiro
    Stewart, Ross A.
    Overed-Sayer, Catherine
    Sleeman, Matthew A.
    May, Richard D.
    BLOOD ADVANCES, 2017, 1 (10) : 577 - 589
  • [27] Respiratory syncytial virus disease is mediated by age-variable IL-33 and innate lymphoid cells
    Saravia, Jordy
    You, Dahui
    Shrestha, Bishwas
    Lee, Greg
    Jaligama, Sridhar
    Rovnaghi, Cynthia
    Bagga, Bindiya
    DeVincenzo, John
    Cormier, Stephania
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [28] STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33-driven type 2 immunopathology
    She, Li
    Barrera, Gema D.
    Yan, Liping
    Alanazi, Hamad H.
    Brooks, Edward G.
    Dube, Peter H.
    Sun, Yilun
    Zan, Hong
    Chupp, Daniel P.
    Zhang, Nu
    Zhang, Xin
    Liu, Yong
    Li, Xiao-Dong
    JCI INSIGHT, 2021, 6 (03)
  • [29] TGFb inhibits IL-33-mediated mast cell activation
    Ndaw, Victor
    Paez, Patrick
    Taruselli, Marcela
    Ryan, John
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [30] Dexamethasone suppresses IL-33-mediated mast cell activation
    Paranjape, Anuya
    Chernusheyich, Oksana
    Ryan, John
    JOURNAL OF IMMUNOLOGY, 2014, 192
12345